Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1 Head & Neck 1 Gynecologic 1 Gastrointestinal 1 Breast 1

Conditions

Locally-advanced Rectal Cancer 1

Interventions

Oxaliplatin 1004 Fluorouracil 800 Capecitabine 764 Gemcitabine 650 Leucovorin 559 Irinotecan 537 Bevacizumab 513 Radiotherapy 460 Cisplatin 440 Drug Therapy 298 Cetuximab 280 Surgical Procedures, Operative 229 Paclitaxel 228 S 1 (combination) 217 pembrolizumab 205 Docetaxel 199 130-nm albumin-bound paclitaxel 196 Nivolumab 193 sintilimab 191 Radiosurgery 190 lenvatinib 180 Folfox protocol 179 Sorafenib 178 Albumin-Bound Paclitaxel 173 apatinib 170 tislelizumab 161 camrelizumab 160 Neoadjuvant Therapy 158 Blood Specimen Collection 154 durvalumab 148

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × ASTX-660 × Gastrointestinal × Clear all

NCT05912075 2024-02-08

PRAAR1

Gustave Roussy, Cancer Campus, Grand Paris

Phase 1 Recruiting

Gastrointestinal

Locally-advanced Rectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡